Thermo Fisher Scientific Inc (TMO)
516.10
+3.26
(+0.64%)
USD |
NYSE |
Nov 21, 16:00
516.08
-0.02
(-0.00%)
After-Hours: 20:00
Thermo Fisher Scientific Revenue (Quarterly): 10.60B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.60B |
| June 30, 2024 | 10.54B |
| March 31, 2024 | 10.34B |
| December 31, 2023 | 10.89B |
| September 30, 2023 | 10.57B |
| June 30, 2023 | 10.69B |
| March 31, 2023 | 10.71B |
| December 31, 2022 | 11.45B |
| September 30, 2022 | 10.68B |
| June 30, 2022 | 10.97B |
| March 31, 2022 | 11.82B |
| December 31, 2021 | 10.70B |
| September 30, 2021 | 9.33B |
| June 30, 2021 | 9.273B |
| March 31, 2021 | 9.906B |
| December 31, 2020 | 10.55B |
| September 30, 2020 | 8.521B |
| June 30, 2020 | 6.917B |
| March 31, 2020 | 6.23B |
| December 31, 2019 | 6.829B |
| September 30, 2019 | 6.272B |
| June 30, 2019 | 6.316B |
| March 31, 2019 | 6.125B |
| December 31, 2018 | 6.507B |
| September 30, 2018 | 5.92B |
| Date | Value |
|---|---|
| June 30, 2018 | 6.078B |
| March 31, 2018 | 5.853B |
| December 31, 2017 | 6.047B |
| September 30, 2017 | 5.116B |
| June 30, 2017 | 4.99B |
| March 31, 2017 | 4.765B |
| December 31, 2016 | 4.953B |
| September 30, 2016 | 4.491B |
| June 30, 2016 | 4.535B |
| March 31, 2016 | 4.295B |
| December 31, 2015 | 4.652B |
| September 30, 2015 | 4.123B |
| June 30, 2015 | 4.271B |
| March 31, 2015 | 3.919B |
| December 31, 2014 | 4.493B |
| September 30, 2014 | 4.171B |
| June 30, 2014 | 4.322B |
| March 31, 2014 | 3.904B |
| December 31, 2013 | 3.467B |
| September 30, 2013 | 3.192B |
| June 30, 2013 | 3.240B |
| March 31, 2013 | 3.192B |
| December 31, 2012 | 3.259B |
| September 30, 2012 | 3.086B |
| June 30, 2012 | 3.108B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
6.23B
Minimum
Mar 2020
11.82B
Maximum
Mar 2022
9.876B
Average
10.56B
Median
Revenue (Quarterly) Benchmarks
| Fonar Corp | 24.96M |
| XWELL Inc | 8.422M |
| ProPhase Labs Inc | 3.146M |
| Applied DNA Sciences Inc | 0.7975M |
| Veracyte Inc | 115.86M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.63B |
| Total Expenses (Quarterly) | 8.714B |
| EPS Diluted (Quarterly) | 4.25 |
| Enterprise Value | 226.18B |
| Gross Profit Margin (Quarterly) | 40.84% |
| Profit Margin (Quarterly) | 15.38% |
| Earnings Yield | 3.09% |
| Operating Earnings Yield | 3.73% |
| Normalized Earnings Yield | 3.198 |